| AI | Artificial Intelligence |
| BID | Bis In Die; Two Times a Day |
| CAAs | Critical Administration Attributes |
| CI | Clinical Impact |
| CPPs | Critical Process Parameters |
| CQAs | Critical Quality Attributes |
| EFTs | Enteral Feeding Tubes |
| EMA | European Medicines Agency |
| FDA | US Federal Drug Administration |
| Fr | French size |
| G (tube) | Gastrostomy tube |
| GI | Gastrointestinal |
| HFI | Human-Factor Impact |
| ICH | International Council for Harmonization of Technical Requirements for Pharmaceutical for Human Use |
| ML | Machine Learning |
| NG | Nasogastric |
| NICU | Neonatal Intensive Care Units |
| NJ | Nasojejunal |
| PFDD | Patient-Focused Drug Development |
| PU | Polyurethane |
| PVC | Polyvinylchloride |
| QbD | Quality by Design |
| QID | Quarter In Die; Four Times a Day |
| QTPP | Quality Target Product Profile |
| TID | Ter In Die; Three Times a Day |
| TPP | Target Product Profile |
| VR | Variability Risk |